Latest news
Loading news…
Pyrefin
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Atlanta, Georgia, United States Founded 2019 For Profit
Pyrefin is a development-stage pharmaceutical company focused on producing EP2 receptor antagonists.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Founded
- 2019
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 1
- HQ
- Atlanta, Georgia, United States
- Region
- Greater Atlanta Area, East Coast, Southern US
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 2.5
- Trend (90d)
- 1.5
Key People at Pyrefin
Co-Founder & Chair of Board of Directors
Chief Executive Officer and Co-Founder
Co-Founder, Board Member and Secretory
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Pyrefin
Loading news…
FAQs about Pyrefin
People who checked this page also checked these
Browse the full Acquirezy directory.